The National Institute for Health and Clinical Excellence (NICE) clinical guideline for T2DM recommends adding a DPP-4 inhibitor instead of a sulfonylurea as second line treatment to first line metformin when there is a considerable hypoglycemia risk or a sulfonylurea is contraindicated or not tolerated [16]
(2023) Role of body mass index and weight change in the risk of cancer: A systematic review and meta-analysis of 66 cohort studies Ryan, Donna H., Ryan Yockey, Sarah (2018) Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over Magkos, Faidon, et al
Are there alternative diabetes and weight options with more lactation data
Hope youll subscribe to this newsletter, and please hit the like button
You deserve to be recognized in such a meaningful way